| Description | Regavirumab (MCA C23), a human monoclonal antibody, targets cytomegalovirus (CMV), human serum albumin (HSA), and amino acetic acid [1]. |
| molecular weight | N/A |
| CAS | 153101-26-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |